BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 34 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $352 | -54.2% | 1,066 | 0.0% | 0.00% | – |
| Q4 2022 | $768 | -23.2% | 1,066 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,066 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 1,066 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 1,066 | -28.3% | 0.00% | – |
| Q4 2021 | $2,000 | -50.0% | 1,487 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 1,487 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 1,487 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | +20.0% | 1,487 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -50.0% | 1,487 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -9.1% | 1,487 | -3.3% | 0.00% | – |
| Q2 2020 | $11,000 | – | 1,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 500,000 | $1,881,000 | 0.06% |
| AJU IB Investment Co., Ltd. | 25,651 | $96,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 53,041 | $199,000 | 0.01% |
| Baker Brothers Advisors | 249,123 | $937,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $49,000 | 0.00% |
| Squarepoint Ops LLC | 27,915 | $105,000 | 0.00% |
| Tekla Capital Management LLC | 6,000 | $23,000 | 0.00% |
| Orion Capital Management LLC | 500 | $2,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 13,300 | $50,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 26 | $0 | 0.00% |